234
Views
14
CrossRef citations to date
0
Altmetric
Perspective

Critical reappraisal of pulmonary artery catheterization and invasive hemodynamic assessment in acute heart failure

, , , &
Pages 417-424 | Published online: 10 Jan 2014

References

  • Swan HJ, Ganz W, Forrester J, Marcus H, Diamond G, Chonette D. Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N. Engl. J. Med. 283(9), 447–451 (1970).
  • Connors AF Jr, Speroff T, Dawson NV et al.; SUPPORT Investigators. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 276(11), 889–897 (1996).
  • Hunt SA, Abraham WT, Chin MH et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119(14), e391–e479 (2009).
  • Lindenfeld J, Albert NM, Boehmer JP et al.; Heart Failure Society of America. HFSA 2010 comprehensive heart failure practice guideline. J. Cardiac Failure 16(6), e1–e2 (2010).
  • McLaughlin VV, Archer SL, Badesch DB et al.; American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J. Am. Coll. Cardiol. 53(17), 1573–1619 (2009).
  • Cappola TP, Felker GM, Kao WH, Hare JM, Baughman KL, Kasper EK. Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. Circulation 105(14), 1663–1668 (2002).
  • Wiener RS, Welch HG. Trends in the use of the pulmonary artery catheter in the United States, 1993–2004. JAMA 298(4), 423–429 (2007).
  • Adams KF Jr, Fonarow GC, Emerman CL et al.; ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am. Heart J. 149(2), 209–216 (2005).
  • Wheeler AP, Bernard GR, Thompson BT et al.; The National Heart, Lung and Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N. Engl. J. Med. 354(21), 2213–2224 (2006).
  • The ESCAPE Investigators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial. JAMA 294(13), 1625–1633 (2005).
  • Sandham JD, Hull RD, Brant RF et al.; Canadian Critical Care Clinical Trials Group. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N. Engl. J. Med. 348(1), 5–14 (2003).
  • Shah MR, Hasselblad V, Stevenson LW et al. Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. JAMA 294(13), 1664–1670 (2005).
  • Oh JK. Echocardiography as a noninvasive Swan-Ganz catheter. Circulation 111(24), 3192–3194 (2005).
  • Temporelli PL, Scapellato F, Eleuteri E, Imparato A, Giannuzzi P. Doppler echocardiography in advanced systolic heart failure: a noninvasive alternative to Swan-Ganz catheter. Circ. Heart Fail. 3(3), 387–394 (2010).
  • Fonarow GC, Stough WG, Abraham WT et al.; OPTIMIZE-HF Investigators and Hospitals. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J. Am. Coll. Cardiol. 50(8), 768–777 (2007).
  • Rosamond W, Flegal K, Furie K et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117(4), e25–146 (2008).
  • Fonarow GC, Abraham WT, Albert NM et al.; OPTIMIZE-HF Investigators and Hospitals. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Arch. Intern. Med. 167(14), 1493–1502 (2007).
  • Fonarow GC, Abraham WT, Albert NM et al.; OPTIMIZE-HF Investigators and Hospitals. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA 297(1), 61–70 (2007).
  • Gheorghiade M, Filippatos G. Reassessing treatment of acute heart failure syndromes: the ADHERE Registry. Eur. Heart J. Supp. 7(Suppl. B), B13–B19 (2005).
  • Felker GM, Pang PS, Adams KF et al.; International AHFS Working Group. Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward. Circ. Heart Fail. 3(2), 314–325 (2010).
  • Pang PS, Komajda M, Gheorghiade M. The current and future management of acute heart failure syndromes. Eur. Heart J. 31(7), 784–793 (2010).
  • Packer M, Carver JR, Rodeheffer RJ et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N. Engl. J. Med. 325(21), 1468–1475 (1991).
  • Cuffe MS, Califf RM, Adams KF Jr et al.; Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 287(12), 1541–1547 (2002).
  • Pang PS, Gheorghiade M, Dihu J et al. Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: analysis from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) trials. Am. Heart J. 161(6), 1067–1072 (2011).
  • Gheorghiade M, Pang PS, Ambrosy AP et al. A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial. Heart Fail. Rev. 17(3), 485–509 (2011).
  • Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am. J. Med. 119(12 Suppl. 1), S3–S10 (2006).
  • Chomsky DB, Lang CC, Rayos G, Wilson JR. Treatment of subclinical fluid retention in patients with symptomatic heart failure: effect on exercise performance. J. Heart Lung Transplant. 16(8), 846–853 (1997).
  • Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW. Preferences for quality of life or survival expressed by patients with heart failure. J. Heart Lung Transplant. 20(9), 1016–1024 (2001).
  • Stevenson LW. Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are relevant. Circulation 113(7), 1020–1027; discussion 1033 (2006).
  • Mullens W, Borowski AG, Curtin RJ, Thomas JD, Tang WH. Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure. Circulation 119(1), 62–70 (2009).
  • Kamath SA, Drazner MH, Tasissa G, Rogers JG, Stevenson LW, Yancy CW. Correlation of impedance cardiography with invasive hemodynamic measurements in patients with advanced heart failure: the BioImpedance CardioGraphy (BIG) substudy of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) Trial. Am. Heart J. 158(2), 217–223 (2009).
  • Uriel N, Torre-Amione G, Milo O et al. Echocardiographic ejection fraction in patients with acute heart failure: correlations with hemodynamic, clinical, and neurohormonal measures and short-term outcome. Eur. J. Heart Fail. 7(5), 815–819 (2005).
  • Abraham WT, Adamson PB, Bourge RC et al.; CHAMPION Trial Study Group. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 377(9766), 658–666 (2011).
  • Chatterjee K, Parmley WW, Ganz W et al. Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation 48(6), 1183–1193 (1973).
  • Chatterjee K. The Swan-Ganz catheters: past, present, and future. A viewpoint. Circulation 119(1), 147–152 (2009).
  • Massie BM, Kramer BL, Topic N. Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses. Circulation 69(6), 1135–1141 (1984).
  • Slawsky MT, Colucci WS, Gottlieb SS et al.; Study Investigators. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Circulation 102(18), 2222–2227 (2000).
  • Lilleberg J, Sundberg S, Nieminen MS. Dose-range study of a new calcium sensitizer, levosimendan, in patients with left ventricular dysfunction. J. Cardiovasc. Pharmacol. 26(Suppl. 1), S63–S69 (1995).
  • Gheorghiade M, Gattis WA, O’Connor CM et al.; Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA 291(16), 1963–1971 (2004).
  • Konstam MA, Gheorghiade M, Burnett JC Jr et al.; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 297(12), 1319–1331 (2007).
  • Schrier RW, Gross P, Gheorghiade M et al.; SALT Investigators. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N. Engl. J. Med. 355(20), 2099–2112 (2006).
  • Shipley JB, Tolman D, Hastillo A, Hess ML. Milrinone: basic and clinical pharmacology and acute and chronic management. Am. J. Med. Sci. 311(6), 286–291 (1996).
  • Hoeper MM, Lee SH, Voswinckel R et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J. Am. Coll. Cardiol. 48(12), 2546–2552 (2006).
  • Hind D, Calvert N, McWilliams R et al. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ 327(7411), 361 (2003).
  • Karakitsos D, Labropoulos N, De Groot E et al. Real-time ultrasound-guided catheterisation of the internal jugular vein: a prospective comparison with the landmark technique in critical care patients. Crit. Care 10, 1–8 (2006).
  • O’Grady Naomi P, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. Clin. Infect. Dis. 35(11), 1281–1307 (2002).
  • Centers for Disease Control and Prevention. Reduction in central line-associated bloodstream infections among patients in intensive care units – Pennsylvania, April 2001–March 2005. MMWR Morb. Mortal Wkly. Rep. 54(40), 1013–1016 (2005).
  • Iberti TJ, Daily EK, Leibowitz AB, Schecter CB, Fischer EP, Silverstein JH; The Pulmonary Artery Catheter Study Group. Assessment of critical care nurses’ knowledge of the pulmonary artery catheter. Crit. Care Med. 22(10), 1674–1678 (1994).
  • Iberti TJ, Fischer EP, Leibowitz AB, Panacek EA, Silverstein JH, Albertson TE; Pulmonary Artery Catheter Study Group. A multicenter study of physicians’ knowledge of the pulmonary artery catheter. JAMA 264(22), 2928–2932 (1990).
  • Gnaegi A, Feihl F, Perret C. Intensive care physicians’ insufficient knowledge of right-heart catheterization at the bedside: time to act? Crit. Care Med. 25(2), 213–220 (1997).
  • Trottier SJ, Taylor RW. Physicians’ attitudes toward and knowledge of the pulmonary artery catheter: Society of Critical Care Medicine membership survey. New Horiz. 5(3), 201–206 (1997).
  • Zarich S, Pust-Marcone J, Amoateng-Adjepong Y, Manthous CA. Failure of a brief educational program to improve interpretation of pulmonary artery occlusion pressure tracings. Intensive Care Med. 26(6), 698–703 (2000).
  • Pinsky MR. Pulmonary artery occlusion pressure. In: Applied Physiology in Intensive Care Medicine. Springer, Berlin, Germany 49–52 (2006).
  • Gnaegi A, Feihl F, Perret C. Intensive care physicians’ insufficient knowledge of right-heart catheterization at the bedside: time to act? Crit. Care Med. 25(2), 213–220 (1997).
  • Burns D, Burns D, Shively M. Critical care nurses’ knowledge of pulmonary artery catheters. Am. J. Crit. Care 5(1), 49–54 (1996).
  • Udelson JE, Orlandi C, Ouyang J et al. Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial. J. Am. Coll. Cardiol. 52(19), 1540–1545 (2008).
  • Ruisi CP, Goldberg RJ, Kennelly BM et al.; GRACE investigators. Pulmonary artery catheterization in patients with acute coronary syndromes. Am. Heart J. 158(2), 170–176 (2009).
  • Wiener RS, Welch HG. Trends in the use of the pulmonary artery catheter in the United States, 1993-2004. JAMA 298(4), 423–429 (2007).
  • Levin PD, Sprung CL. Another point of view: no swan song for the pulmonary artery catheter. Crit. Care Med. 33(5), 1123–1124 (2005).
  • Beller GA, Bonow RO, Fuster V; American College of Cardiology Foundation; American Heart Association; American College of Physicians Task Force on Clinical Competence and Training. ACCF 2008 Recommendations for Training in Adult Cardiovascular Medicine Core Cardiology Training (COCATS 3) (revision of the 2002 COCATS Training Statement). J. Am. Coll. Cardiol. 51(3), 335–338 (2008).
  • Konstam MA, Jessup M, Francis GS, Mann DL, Greenberg B. Advanced heart failure and transplant cardiology: a subspecialty is born. J. Am. Coll. Cardiol. 53(10), 834–836 (2009).
  • Mueller HS, Chatterjee K, Davis KB et al. ACC Expert Consensus Document. Present use of bedside right heart catheterization in patients with cardiac disease. American College of Cardiology. J. Am. Coll. Cardiol. 32(3), 840–864 (1998).
  • Tuggle D. Obtaining pulmonary artery catheter data is too labor intense to be reliable. Crit. Care Med. 37(5), 1833; author reply 1833 (2009).
  • Vincent JL, Pinsky MR, Sprung CL et al. The pulmonary artery catheter: in medio virtus. Crit. Care Med. 36(11), 3093–3096 (2008).
  • Ospina-Tascón GA, Cordioli RL, Vincent JL. What type of monitoring has been shown to improve outcomes in acutely ill patients? Intensive Care Med. 34(5), 800–820 (2008).
  • Pinsky MR, Vincent JL. Let us use the pulmonary artery catheter correctly and only when we need it. Crit. Care Med. 33(5), 1119–1122 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.